Galmed Pharmaceuticals vs Upstream Bio
Galmed Pharmaceuticals vs Upstream Bio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Galmed Pharmaceuticals is on 39/100 and Upstream Bio on 61/100.
Where each one leads
Galmed Pharmaceuticals
- agent readiness: 50/100 against 39/100
- domain rating: 38/100 against 32/100
Upstream Bio
- our overall score: 61/100 against 39/100
- headcount: 75 against 11
- headcount growth: +43.4% against -7.8%
- LinkedIn following: 11,799 against 2,730
At a glance
| Measure | Galmed Pharmaceuticals | Upstream Bio |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing treatments for liver, metabolic, and inflammatory diseases. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Biotech, Drug Discovery, Clinical Trials | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2000 | 2021 |
| Headquarters | Tel Aviv, Israel | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Galmed Pharmaceuticals | Upstream Bio |
|---|---|---|
| Employees | 11 | 75 |
| Headcount growthLast 12 months | -7.8% | +43.4% |
| Total funding | Not published | $400M |
| Latest round | Bootstrapped | Series B |
| LinkedIn followers | 2,730 | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Galmed Pharmaceuticals | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 39/100 | 61/100 |
| Traction | 11/100 | 59/100 |
| Team | Not published | 70/100 |
| Search visibility | 20/100 | 37/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Galmed Pharmaceuticals | Upstream Bio |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Galmed Pharmaceuticals vs Upstream Bio: common questions
Which is better, Galmed Pharmaceuticals or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Galmed Pharmaceuticals and Upstream Bio compare on the numbers?
Galmed Pharmaceuticals leads on agent readiness (50/100 against 39/100), domain rating (38/100 against 32/100). Upstream Bio leads on our overall score (61/100 against 39/100), headcount (75 against 11), headcount growth (+43.4% against -7.8%), LinkedIn following (11,799 against 2,730).
Read the full Galmed Pharmaceuticals review and pricing or the Upstream Bio review and pricing. You can also browse other Galmed Pharmaceuticals alternatives we track.